The clinical management of bladder cancer (BC) has become an increasing challenge due
to high incidence rate of BC, malignant behavior of cancer cells and drug resistance. The …

Long non-coding RNAs (lncRNAs) are key regulators of numerous intracellular processes
leading to tumorigenesis. They are frequently deregulated in cancer, functioning as …

Background Necroptosis is a type of programmed cell death, and recent researches have
showed that lncRNAs could regulate the process of necroptosis in multiple cancers. We tried …

Background An increasing body of evidence has supported that long non-coding RNAs
(lncRNAs) can play as essential roles of various physiological process and pathological …

Background Laryngeal squamous cell carcinoma (LSCC) is the most common squamous
cell carcinoma. Though significant effort has been focused on molecular pathogenesis …

Immunotherapy has been established as a promising therapy for different cancer types.
However, many patients experience primary or secondary resistance to treatment. Immune …

Bladder cancer is one of the most common genitourinary malignant cancers worldwide. Cell
death processes, including apoptosis, ferroptosis, and necrosis, provide novel clinical and …

The tight relationship between ferroptotic cell death and immune response demonstrated by
recent studies enlightened us to detect the underlying roles of ferroptosis‐related long …

Purpose Identify immune-related lncRNA (IRL) signature related to the prognosis and
immunotherapeutic efficiency for bladder cancer (BLCA) patients. Methods A total of 397 …

Bladder cancer (BLCA) is one of the most common urological cancer with increasing cases
and deaths every year. In the present study, we aim to construct an immune‐related …